Picture of Aarti Drugs logo

AARTIDRUGS Aarti Drugs Cashflow Statement

0.000.00%
in flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Annual cashflow statement for Aarti Drugs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

2019
March 31st
2020
March 31st
C2021
March 31st
2022
March 31st
2023
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IAS
IAS
IAS
IAS
IAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line1,3101,8533,6902,7002,242
Depreciation
Non-Cash Items-64.356.7-16.44.98-6.6
Unusual Items
Other Non-Cash Items
Changes in Working Capital-241110-2,623-2,509-1,396
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Other Operating Cash Flow
Cash from Operating Activities1,4312,5071,5506961,342
Capital Expenditures-743-480-882-1,520-1,648
Purchase of Fixed Assets
Other Investing Cash Flow Items12614816531.18.46
Sale of Fixed Assets
Sale/Maturity of Investment
Other Investing Cash Flow
Cash from Investing Activities-617-332-718-1,489-1,640
Financing Cash Flow Items-404-352-230-344-362
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-801-2,154-811920165
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash13.521.320.4128-132